Gd(ABE-DTTA), a Novel Contrast Agent, at the MRI-Effective Dose Shows Absence of Deleterious Physiological Effects in Dogs

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Pharmacology

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000094864PMID 16877874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gd(ABE‐DTTA)‐enhanced cardiac MRI for the diagnosis of ischemic events in the heart

  2005cited by this paper
• Determining Tissue Kinetics of Gd(ABE-DTTA), an Infarct-Avid, Persistent Contrast-Agent in Canine Myocardial Infarction

  2004cited by this paper
• Hepatic effects of halothane, isoflurane or sevoflurane anaesthesia in dogs.

  2003cited by this paper
• In Vivo T1 Mapping of Canine Hearts Using Gd(ABE-DTTA) in an Ischemia-Reperfusion Model

  2003cited by this paper
• Low-flow desflurane and sevoflurane anesthesia minimally affect hepatic integrity and function in elderly patients.

  2000cited by this paper
• Synthesis and in vivo evaluation of new contrast agents for cardiac MRI.

  1999cited by this paper
• Special considerations in interpreting liver function tests.

  1999cited by this paper
• Lateralization of human temporal lobe epilepsy by 31P NMR spectroscopic imaging at 4.1 T

  1998cited by this paper
• In vivo Characterization of Gd(BME‐DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function

  1997cited by this paper
• In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd (BME-DTTA).

  1995cited by this paper
• Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases.

  1995cited by this paper
• Comparison of the effects of sevoflurane, isoflurane and halothane on indocyanine green clearance.

  1995cited by this paper
• Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms.

  1995cited by this paper
• Relationship of aminotransferases to liver histological status in chronic hepatitis C.

  1995cited by this paper
• Gadolinium complexes of [(myristoyloxy)propyl]diethylenetriaminetetraacetate: new lipophilic, fatty acyl conjugated NMR contrast agents.

  1992cited by this paper
• Early effect of gadopentetate and iodinated contrast media on rabbit kidneys.

  1992cited by this paper
• Fatty‐acyl iminopolycarboxylates: Lipophilic bifunctional contrast agents for NMR imaging

  1991cited by this paper
• Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis.

  1990cited by this paper
• Comparison of the biodistribution of manganese-54 DTPA and gadolinium-153 DTPA in dogs.

  1987cited by this paper
• Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration.

  1986cited by this paper
• Liver damage as a potential source of error in the estimation of myocardial infarct size from plasma creatine kinase activity.

  1985cited by this paper
• Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

  1984cited by this paper

• Molecular imaging of myocardial necrosis: an updated mini-review

  2020cites this paper
• Myocardial tissue characterization by combining late gadolinium enhancement imaging and percent edema mapping: a novel T2 map-based MRI method in canine myocardial infarction

  2018cites this paper
• In Vitro Longitudinal Relaxivity Profile of Gd(ABE-DTTA), an Investigational Magnetic Resonance Imaging Contrast Agent

  2016cites this paper
• Acute infarct selective MRI contrast agent

  2012cites this paper
• Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping.

  2011cites this paper
• Cardiovascular magnetic resonance imaging for in vivo assessment of the age of myocardial infarct and for identification of signifact coronary heart disease in patients with peripheral arterial disease

  2011cites this paper
• THE SIGNIFICANCE OF AN INTRINSIC MRI PARAMETER IN THE DIAGNOSIS OF MYOCARDIAL ISCHEMIA Ph

  2010cites this paper
• Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR

  2010cites this paper
• Head‐to‐head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model

  2008cites this paper
• In vivo myocardial tissue kinetics of Gd(ABE‐DTTA), a tissue‐persistent contrast agent

  2007cites this paper
• Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.

  2007cites this paper